Functional MRI and MR Spectroscopy Utilization in Jeddah Hospitals

Lamis K. Jada¹, Nabeel Mishah², Khalid Gh. Alsafi³, Sarah Hagi³, Mawya A. Khafaji³, Hanan Y. Abbas¹, Saddig D. Jastaniah^1*

¹Department of Diagnostic Radiology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, KSA.
²Radiology Department, King Abdulaziz University Hospital, Jeddah, KSA.
³Department of Radiology, School of Medicine, King Abdulaziz University, Jeddah, KSA.

DOI: 10.4236/ojmi.2015.53021                

Abstract

Functional magnetic resonance imaging “fMRI” and magnetic resonance spectroscopy “MRS” are two crucial milestones that were introduced apart from one another into brain imaging and their implementation in major local cities is eventual step. Thus, the purpose of this study was to compare those techniques in terms of their clinical utilization in patient care delivery among the major governmental and private hospitals within Jeddah city. The study initially included eighteen hospitals to identify whether they were utilizing fMRI and MRS in their clinical practice. Out of the 18 hospitals under study only one hospital (5.6%) had both fMRI and MRS software; 7 (38.9%) had MRS but not fMRI; 4 (22.2%) did not have fMRI or MRS; and 6 (33.3%) hospitals had no MRI machine at all. Out of the eight hospitals applying MRS with one being excluded, the starting date of application was 2002 in 4 (57.1%) hospitals, 2004 in 1 (14.3%) hospital, and 2006 in 2 (28.6%) hospitals. The frequency of doing MRS was once a week in 2 (28.6%) hospitals, 2-3 cases/week in 3 (42.9%) hospitals, 5-10 cases/week in 1 (14.3%) hospital, and once every 6 months in 1 (14.3%) hospital. On the other hand, fMRI was applied only by one hospital starting in 2000 and was soon dismissed due to its time consumption and the inability of patients to accurately follow given instructions. It was concluded that MRS was more widely utilized compared to fMRI. Later on, a follow-up survey in the year of 2014 demonstrated that MRS has started to become a standard service in most hospitals whereas fMRI was still being unrecognized.

Keywords

Brain, fMRI, Activation, MRS, Metabolites

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Friman, O. (2003) Adaptive Analysis of Functional MRI Data. PhD Dissertation, Linkoping University, Sweden.
[2]	Savoy, R.L. (1999) Functional Magnetic Resonance Imaging (fMRI). Encyclopedia of Neuroscience, 2nd Edition, Elsevier, Amsterdam.
[3]	Schwindack, C., Siminotto, E., Meyer, M., McNamara, A., Marshall, I., Wardlaw, J.M. and Whittle, I.R. (2005) Real- Time Functional Magnetic Resonance Imaging (rt-fMRI) in Patients with Brain Tumours: Preliminary Findings Using Motor and Language Paradigms. British Journal of Neurosurgery, 19, 25-32. http://dx.doi.org/10.1080/02688690500089621
[4]	Sulzer, J., Haller, S., Scharnowski, F., Weiskopf, N., Birbaumer, N., Blefari, M.L. and Sitaram, R. (2013) Real-Time fMRI Neurofeedback: Progress and Challenges. Neuroimage, 76, 386-399. http://dx.doi.org/10.1016/j.neuroimage.2013.03.033
[5]	Bookheimer, S.Y., Strojwas, M.H., Cohen, M.S., Saunders, A.M., Pericak-Vance, M.A., Mazziotta, J.C. and Small, G.W. (2000) Patterns of Brain Activation in People at Risk for Alzheimer’s Disease. New England Journal of Medicine, 343, 450-456. http://dx.doi.org/10.1056/NEJM200008173430701
[6]	Wagner, A.D. (2000) Early Detection of Alzheimer’s Disease: An fMRI Marker for People at Risk? Nature Neuroscience, 3, 973-974. http://dx.doi.org/10.1038/79904
[7]	Weinberger, D.R., Mattay, V., Callicott, J., Kotrla, K., Santha, A., van Gelderen, P. and Frank, J. (1996) fMRI Applications in Schizophrenia Research. Neuroimage, 4, S118-S126. http://dx.doi.org/10.1006/nimg.1996.0062
[8]	Beauregard, M., Leroux, J.M., Bergman, S., Arzoumanian, Y., Beaudoin, G., Bourgouin, P. and Stip, E. (1998) The Functional Neuroanatomy of Major Depression: An fMRI Study Using an Emotional Activation Paradigm. Neuroreport, 9, 3253-3258. http://dx.doi.org/10.1097/00001756-199810050-00022
[9]	Breiter, H.C. and Rauch, S.L. (1996) Functional MRI and the Study of OCD: From Symptom Provocation to Cognitive-Behavioral Probes of Cortico-Striatal Systems and the Amygdala. Neuroimage, 4, S127-S138. http://dx.doi.org/10.1006/nimg.1996.0063
[10]	Adler, C.M., McDonough-Ryan, P., Sax, K.W., Holland, S.K., Arndt, S. and Strakowski, S.M. (2000) fMRI of Neuronal Activation with Symptom Provocation in Unmedicated Patients with Obsessive Compulsive Disorder. Journal of Psychiatric Research, 34, 317-324. http://dx.doi.org/10.1016/S0022-3956(00)00022-4
[11]	Teicher, M.H., Anderson, C.M., Polcari, A., Glod, C.A., Maas, L.C. and Renshaw, P.F. (2000) Functional Deficits in Basal Ganglia of Children with Attention-Deficit/Hyperactivity Disorder Shown with Functional Magnetic Resonance Imaging Relaxometry. Nature medicine, 6, 470-473. http://dx.doi.org/10.1038/74737
[12]	Rudkin, T.M. and Arnold, D.L. (1999) Proton Magnetic Resonance Spectroscopy for the Diagnosis and Management of Cerebral Disorders. Archives of neurology, 56, 919-926. http://dx.doi.org/10.1001/archneur.56.8.919
[13]	Castillo, M., Kwock, L. and Mukherji, S.K. (1996) Clinical Applications of Proton MR Spectroscopy. American Journal of Neuroradiology, 17, 1-16.
[14]	Penrice, J., Cady, E.B., Lorek, A., Wylezinska, M., Amess, P.N., Aldridge, R.F. and Reynolds, E.O.R. (1996) Proton Magnetic Resonance Spectroscopy of the Brain in Normal Preterm and Term Infants, and Early Changes after Perinatal Hypoxia-Ischemia. Pediatric Research, 40, 6-14. http://dx.doi.org/10.1203/00006450-199607000-00002
[15]	Amess, P.N., Penrice, J., Wylezinska, M., Lorek, A., Townsend, J., Wyatt, J.S. and Stewart, A. (1999) Early Brain Proton Magnetic Resonance Spectroscopy and Neonatal Neurology Related to Neurodevelopmental Outcome at 1 Year in Term Infants after Presumed Hypoxic—Ischaemic Brain Injury. Developmental Medicine & Child Neurology, 41, 436-445.
[16]	Zimmerman, R.A. and Wang, Z.J. (1997) The Value of Proton MR Spectroscopy in Pediatric Metabolic Brain Disease. American Journal of Neuroradiology, 18, 1872-1879.
[17]	Grossman, R.I., Lenkinski, R.E., Ramer, K.N., Gonzalez-Scarano, F. and Cohen, J.A. (1992) MR Proton Spectroscopy in Multiple Sclerosis. American Journal of Neuroradiology, 13, 1535-1543.
[18]	Shonk, T.K., Moats, R.A., Gifford, P., Michaelis, T., Mandigo, J.C., Izumi, J. and Ross, B.D. (1995) Probable Alzheimer Disease: Diagnosis with Proton MR Spectroscopy. Radiology, 195, 65-72. http://dx.doi.org/10.1148/radiology.195.1.7892497
[19]	Brown, M.S., Simon, J.H., Stemmer, S.M., Stears, J.C., Scherzinger, A., Cagnoni, P.J. and Jones, R.B. (1995) MR and Proton Spectroscopy of White Matter Disease Induced by High-Dose Chemotherapy with Bone Marrow Transplant in Advanced Breast Carcinoma. American Journal of Neuroradiology, 16, 2013-2020.
[20]	Brown, M.S., Stemmer, S.M., Simon, J.H., Stears, J.C., Jones, R.B., Cagnoni, P.J. and Sheeder, J.L. (1998) White Matter Disease Induced by High-Dose Chemotherapy: Longitudinal Study with MR Imaging and Proton Spectroscopy. American Journal of Neuroradiology, 19, 217-221.
[21]	Breiter, S.N., Arroyo, S., Mathews, V.P., Lesser, R.P., Bryan, R.N. and Barker, P.B. (1994) Proton MR Spectroscopy in Patients with Seizure Disorders. American Journal of Neuroradiology, 15, 373-384.
[22]	Achten, E., Boon, P., Van De Kerckhove, T., Caemaert, J., De Reuck, J. and Kunnen, M. (1997) Value of Single-Voxel Proton MR Spectroscopy in Temporal Lobe Epilepsy. American Journal of Neuroradiology, 18, 1131-1139.
[23]	Chang, L., Miller, B.L., McBride, D., Cornford, M., Oropilla, G., Buchthal, S. and Ernst, T. (1995) Brain Lesions in Patients with AIDS: H-1 MR Spectroscopy. Radiology, 197, 525-531. http://dx.doi.org/10.1148/radiology.197.2.7480706
[24]	Burtscher, I.M. and Holtas, S. (2001) Proton Magnetic Resonance Spectroscopy in Brain Tumours: Clinical Applications. Neuroradiology, 43, 345-352. http://dx.doi.org/10.1007/s002340000427
[25]	Richards, T.L., Berninger, V.W., Aylward, E.H., Richards, A.L., Thomson, J.B., Nagy, W.E. and Abbott, R.D. (2002) Reproducibility of Proton MR Spectroscopic Imaging (PEPSI): Comparison of Dyslexic and Normal-Reading Children and Effects of Treatment on Brain Lactate Levels during Language Tasks. American Journal of Neuroradiology, 23, 1678-1685.
[26]	Gussew, A., Rzanny, R., Erdtel, M., Scholle, H.C., Kaiser, W.A., Mentzel, H.J. and Reichenbach, J.R. (2010) Time-Resolved Functional 1H MR Spectroscopic Detection of Glutamate Concentration Changes in the Brain during Acute Heat Pain Stimulation. Neuroimage, 49, 1895-1902. http://dx.doi.org/10.1016/j.neuroimage.2009.09.007
[27]	Narayana, A., Chang, J., Thakur, S., Huang, W., Karimi, S., Hou, B. and Gutin, P.H. (2007) Use of MR Spectroscopy and Functional Imaging in the Treatment Planning of Gliomas. The British Journal of Radiology, 80, 347-354. http://dx.doi.org/10.1259/bjr/65349468
[28]	Modo, M. and Bulte, J.W. (2011) Magnetic Resonance Neuroimaging. Methods in Molecular Biology, 711. http://dx.doi.org/10.1007/978-1-61737-992-5
[29]	Vanhamme, L., van den Boogaart, A. and Van Huffel, S. (1997) Improved Method for Accurate and Efficient Quantification of MRS Data with Use of Prior Knowledge. Journal of Magnetic Resonance, 129, 35-43. http://dx.doi.org/10.1006/jmre.1997.1244
[30]	Moller-Hartmann, W., Herminghaus, S., Krings, T., Marquardt, G., Lanfermann, H., Pilatus, U. and Zanella, F. (2002) Clinical Application of Proton Magnetic Resonance Spectroscopy in the Diagnosis of Intracranial Mass Lesions. Neuroradiology, 44, 371-381. http://dx.doi.org/10.1007/s00234-001-0760-0
[31]	Majos, C., Alonso, J., Aguilera, C., Serrallonga, M., Coll, S., Acebes, J.J. and Gili, J. (2003) Utility of Proton MR Spectroscopy in the Diagnosis of Radiologically Atypical Intracranial Meningiomas. Neuroradiology, 45, 129-136.
[32]	Kwock, L., Smith, J.K., Castillo, M., Ewend, M.G., Collichio, F., Morris, D.E. and Cush, S. (2006) Clinical Role of Proton Magnetic Resonance Spectroscopy in Oncology: Brain, Breast, and Prostate Cancer. The Lancet Oncology, 7, 859-868. http://dx.doi.org/10.1016/S1470-2045(06)70905-6
[33]	Soares, D.P. and Law, M. (2009) Magnetic Resonance Spectroscopy of the Brain: Review of Metabolites and Clinical Applications. Clinical Radiology, 64, 12-21. http://dx.doi.org/10.1016/j.crad.2008.07.002
[34]	Soher, B.J., Young, K., Govindaraju, V. and Maudsley, A.A. (1998) Automated Spectral Analysis III: Application to in Vivo Proton MR Spectroscopy and Spectroscopic Imaging. Magnetic Resonance in Medicine, 40, 822-831. http://dx.doi.org/10.1002/mrm.1910400607
[35]	Helms, G. and Piringer, A. (2001) Restoration of Motion—Related Signal Loss and Line—Shape Deterioration of Proton MR Spectra Using the Residual Water as Intrinsic Reference. Magnetic Resonance in Medicine, 46, 395-400. http://dx.doi.org/10.1002/mrm.1203
[36]	Thiel, T., Czisch, M., Elbel, G.K. and Hennig, J. (2002) Phase Coherent Averaging in Magnetic Resonance Spectroscopy Using Interleaved Navigator Scans: Compensation of Motion Artifacts and Magnetic Field Instabilities. Magnetic Resonance in Medicine, 47, 1077-1082. http://dx.doi.org/10.1002/mrm.10174
[37]	Matthews, P.M., Honey, G.D. and Bullmore, E.T. (2006) Applications of fMRI in Translational Medicine and Clinical Practice. Nature Reviews Neuroscience, 7, 732-744. http://dx.doi.org/10.1038/nrn1929
[38]	Schleim, S. and Roiser, J.P. (2009) fMRI in Translation: The Challenges Facing Real-World Applications. Frontiers in Human Neuroscience, 3, 63. http://dx.doi.org/10.3389/neuro.09.063.2009
[39]	Horská, A. and Barker, P.B. (2010) Imaging of Brain Tumors: MR Spectroscopy and Metabolic Imaging. Neuroimaging Clinics of North America, 20, 293-310. http://dx.doi.org/10.1016/j.nic.2010.04.003
[40]	Raizada, R.D. and Kriegeskorte, N. (2010) Pattern-Information fMRI: New Questions Which It Opens up and Challenges Which Face It. International Journal of Imaging Systems and Technology, 20, 31-41. http://dx.doi.org/10.1002/ima.20225
[41]	Bharath, R.D. (2014) Functional MRI: Genesis, State of the Art and the Sequel. The Indian Journal of Radiology & Imaging, 24, 6-12. http://dx.doi.org/10.4103/0971-3026.130684